Preferred Label : Sildenafil Citrate;

MeSH definition : A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.;

MeSH synonym : Citrate, Sildenafil; 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate;

MeSH Hyperonym : sildenafil;

MeSH hyponym : viagra; homosildenafil; UK 92480-10; revatio; NCX-911; NCX 911; NCX911; UK 92480 10; UK 9248010; UK-92,480-10; UK 92,480 10;

Related MeSH term : sildenafil lactate; sildenafil nitrate; desmethyl sildenafil; hydroxyhomosildenafil; acetildenafil; Lactate, Sildenafil; Nitrate, Sildenafil; Sildenafil, Desmethyl; Desmethylsildenafil;

MeSH Related Number : 0Z3JH0S0QK; 139755-83-2; 3M7OB98Y7H; 80X7B1F6NW; L6WO34R9YG; TP0E2BW57H;

Wikipedia link : https://en.wikipedia.org/wiki/Acetildenafil;

Is substance : O;

UNII : BW9B0ZE037;

Details


Main resources

You can consult :

A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.

https://www.has-sante.fr/jcms/p_3562967/fr/viagra-sildenafil-dysfonction-erectile
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
sildenafil
Orally Disintegrating Film Dosage Form
evaluation of the transparency committee
sildenafil
Sildenafil Citrate
erectile dysfunction

---
https://www.has-sante.fr/jcms/p_3329204/fr/viagra-sildenafil
2022
France
evaluation of the transparency committee
sildenafil
sildenafil
viagra
Sildenafil Citrate

---
https://www.has-sante.fr/portail/jcms/c_2869236/fr/balcoga
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
drugs, generic
Sildenafil Citrate
sildenafil
hypertension, pulmonary
phosphodiesterase 5 inhibitors
adult
child
adolescent

---
https://www.has-sante.fr/portail/jcms/c_2839005/fr/sildenafil-ohre-pharma
2018
false
false
false
France
French
evaluation of the transparency committee
sildenafil
sildenafil
Sildenafil Citrate

---
https://www.has-sante.fr/portail/jcms/c_2831898/fr/xybilun
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
treatment outcome
Sildenafil Citrate
administration, oral
erectile dysfunction
Buccal Film Dosage Form
urological agents
sildenafil
insurance, health, reimbursement
phosphodiesterase 5 inhibitors

---
https://www.has-sante.fr/portail/jcms/c_2831904/fr/sildenafil-eg
2018
false
false
false
France
French
evaluation of the transparency committee
sildenafil
sildenafil
Sildenafil Citrate

---
https://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-phosphodiesterase-v
2018
false
true
false
France
vasodilator agents
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug monitoring
Sildenafil Citrate
erectile dysfunction
drug information
phosphodiesterase 5 inhibitors

---
https://ansm.sante.fr/informations-de-securite/Le-sildenafil-Revatio-et-Viagra-et-ses-generiques-ne-doit-pas-etre-utilise-pour-traiter-le-retard-de-croissance-intra-uterin
2018
false
false
false
France
French
pharmacovigilance note
Sildenafil Citrate
fetal growth retardation
persistent fetal circulation syndrome
Off-Label use
Newborn persistent pulmonary hypertension
pregnancy
sildenafil

---
https://www.has-sante.fr/portail/jcms/c_2842734/fr/sildenafil-arrow
2018
false
false
false
France
French
evaluation of the transparency committee
sildenafil
sildenafil
Sildenafil Citrate

---
https://www.has-sante.fr/portail/jcms/c_2745879/fr/granpidam
2017
false
France
French
Sildenafil Citrate
drugs, generic
Product containing precisely sildenafil (as sildenafil citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
child
adolescent
Pulmonary arterial hypertension associated with congenital heart disease (disorder)
idiopathic pulmonary arterial hypertension
adult
treatment outcome
3',5'-Cyclic-GMP phosphodiesterases
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
Familial Primary Pulmonary Hypertension

---
https://www.ema.europa.eu/medicines/human/EPAR/Granpidam
2017
false
United Kingdom
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
europe
pregnancy
breast feeding
drugs, generic
Product containing precisely sildenafil (as sildenafil citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
Pulmonary arterial hypertension associated with connective tissue disease (disorder)
Pulmonary arterial hypertension associated with congenital heart disease (disorder)
adolescent
child
idiopathic pulmonary arterial hypertension
adult
drug interactions
treatment outcome
drug evaluation
3',5'-Cyclic-GMP phosphodiesterases
drug approval
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet
Familial Primary Pulmonary Hypertension

---
http://www.has-sante.fr/portail/jcms/c_2747227/fr/cetinor
http://www.has-sante.fr/portail/jcms/c_2747227/fr/cetinor-sildenafil-inhibiteur-de-la-phosphodiesterase-de-type-5
2017
false
false
France
French
Sildenafil Citrate
evaluation of the transparency committee
drugs, generic
insurance, health, reimbursement
Product containing precisely sildenafil (as sildenafil citrate) 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely sildenafil (as sildenafil citrate) 50 milligram/1 each conventional release oral tablet (clinical drug)
guidelines for drug use
erectile dysfunction
vasodilator agents
treatment outcome
administration, oral
adult
drug approval
sildenafil
phosphodiesterase 5 inhibitors

---
http://www.has-sante.fr/portail/jcms/c_2761865/fr/granpidam
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Product containing precisely sildenafil (as sildenafil citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
Sildenafil Citrate

---
http://www.has-sante.fr/portail/jcms/c_2723192/fr/mysildecard
2016
false
France
French
English
Sildenafil Citrate
drugs, generic
Product containing precisely sildenafil (as sildenafil citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
child
adolescent
phosphodiesterase 5 inhibitors
treatment outcome
administration, oral
hypertension, pulmonary
vasodilator agents
adult
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Mysildecard
2016
false
United Kingdom
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
europe
pregnancy
breast feeding
child
drugs, generic
adolescent
Product containing precisely sildenafil (as sildenafil citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
adult
drug interactions
treatment outcome
drug evaluation
3',5'-Cyclic-GMP phosphodiesterases
drug approval
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Sildenafil-Teva
2012
false
United Kingdom
French
English
syndication feed
Sildenafil Citrate
Sildenafil Citrate
vasodilator agents
sildenafil
drugs, generic
vasodilator agents
administration, oral
tablets
drug approval
erectile dysfunction
adult
treatment outcome
drug labeling
drug interactions
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Revatio
2012
false
United Kingdom
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
europe
pregnancy
breast feeding
adolescent
child
adult
drug interactions
treatment outcome
drug evaluation
3',5'-Cyclic-GMP phosphodiesterases
drug approval
orphan drug production
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Vizarsin
2012
false
United Kingdom
French
English
syndication feed
Sildenafil Citrate
Sildenafil Citrate
sildenafil
erectile dysfunction
tablets
administration, oral
drugs, generic
drug approval
treatment outcome
drug labeling
adult
aged
drug interactions
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
package leaflet
summary of product characteristics

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/revatio_06062012_avis_ct12241.pdf
http://www.has-sante.fr/portail/jcms/c_1260367/revatio
2012
false
France
French
evaluation of the transparency committee
Sildenafil Citrate
Sildenafil Citrate
administration, oral
hypertension, pulmonary
child
adolescent
treatment outcome
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
orphan drug production
vasodilator agents
vasodilator agents
tablets
pharmaceutical solutions
clinical trials as topic
other peripheral vasodilators

---
http://www.has-sante.fr/portail/jcms/c_1294158/revatio-par-voie-orale-sildenafil-inhibiteur-de-la-phosphodiesterase
http://www.has-sante.fr/portail/jcms/c_1294059/revatio-orale-synthese-06062012
http://www.has-sante.fr/portail/jcms/c_1262534/revatio-06062012-avis-ct12241
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
Sildenafil Citrate
Sildenafil Citrate
administration, oral
phosphodiesterase inhibitors
phosphodiesterase inhibitors
pharmaceutical solutions
child
hypertension, pulmonary
adolescent
heart defects, congenital
treatment outcome
orphan drug production
tablets
clinical trials as topic
survival analysis

---
http://www.cochrane.org/fr/CD009427
http://www.cochrane.org/fr/CD009427/traitements-au-viagra-citrate-de-sildenafil-pour-le-dysfonctionnement-erectile-chez-les-patients-de-sexe-masculin-ages-de-plus-de-18-ans-atteints-de-sclerose-en-plaques.
2012
false
true
false
United Kingdom
France
treatment outcome
Sildenafil Citrate
Sildenafil Citrate
sildenafil
meta-analysis
french abstract
erectile dysfunction
multiple sclerosis

---
http://www.cochrane.org/fr/CD005494
2011
false
true
false
France
United Kingdom
Sildenafil Citrate
infant, newborn
treatment outcome
review of literature
french abstract
persistent fetal circulation syndrome

---
http://www.has-sante.fr/portail/jcms/c_1294155/revatio-par-voie-intraveineuse-sildenafil-inhibiteur-de-la-phosphodiesterase
http://www.has-sante.fr/portail/jcms/c_1294055/revatio-injectable-synthese-16112011
http://www.has-sante.fr/portail/jcms/c_1247949/revatio-16112011-avis-ct11475
2011
false
France
French
guidelines for drug use
Sildenafil Citrate
evaluation of the transparency committee
phosphodiesterase inhibitors
insurance, health, reimbursement
treatment outcome
hypertension, pulmonary
injections, intravenous
orphan drug production
adult
aged

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-05/revatio_16112011_avis_ct11475.pdf
http://www.has-sante.fr/portail/jcms/c_1244192/revatio
2011
false
France
French
evaluation of the transparency committee
Sildenafil Citrate
Sildenafil Citrate
orphan drug production
hypertension, pulmonary
phosphodiesterase 5 inhibitors
injections, intravenous
treatment outcome
other peripheral vasodilators
adult
aged
clinical trials as topic

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/synthese_davis_reevaluation_htap_2011-05-12_12-18-35_386.pdf
http://www.has-sante.fr/portail/jcms/c_1053751/medicaments-de-lhypertension-arterielle-pulmonaire-idiopathique-ou-associee-a-une-connectivite
2011
false
France
French
evaluation of the transparency committee
guidelines for drug use
Sildenafil Citrate
Tadalafil
hypertension, pulmonary
collagen diseases
epoprostenol
antihypertensive agents
sulfonamides
treprostinil
epoprostenol
phosphodiesterase 5 inhibitors
iloprost
receptors, endothelin
ambrisentan
phenylpropionates
DERMATITIS
survival analysis
Antihypertensives for pulmonary arterial hypertension
treatment outcome
pyridazines
Bosentan

---
https://www.ema.europa.eu/medicines/human/EPAR/Sildenafil-ratiopharm
2010
false
United Kingdom
French
English
syndication feed
Sildenafil Citrate
Sildenafil Citrate
Product containing precisely sildenafil (as sildenafil citrate) 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely sildenafil (as sildenafil citrate) 50 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely sildenafil (as sildenafil citrate) 100 milligram/1 each conventional release oral tablet (clinical drug)
drug interactions
drug approval
drug labeling
sildenafil
tablets
administration, oral
drugs, generic
adult
aged
treatment outcome
erectile dysfunction
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Viagra
2009
false
United Kingdom
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
erectile dysfunction
vasodilator agents
treatment outcome
drug evaluation
administration, oral
adult
aged
drug interactions
vasodilator agents
drug labeling
drug approval
sildenafil
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Sildenafil-Actavis
2009
false
United Kingdom
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
sildenafil
drugs, generic
tablets
administration, oral
erectile dysfunction
drug approval
drug labeling
treatment outcome
drug interactions
adult
aged
package leaflet
drug evaluation
summary of product characteristics

---
https://www.pharmacoclin.ch/_library/pdf/2008_35_5.pdf
2008
false
Switzerland
French
Sildenafil Citrate
phosphodiesterase 5 inhibitors
fraud
pharmaceutical preparations
product surveillance, postmarketing
internet
aphrodisiacs
milk substitutes
world health organization
adverse drug reaction reporting systems
heparin
counterfeit drugs
journal article

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Revatio_Fr.pdf
2007
false
Canada
French
Sildenafil Citrate
hypertension, pulmonary
vasodilator agents
phosphodiesterase 5 inhibitors
other peripheral vasodilators
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_400878
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032457.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct_2255_revatio_ang.pdf
2006
false
France
French
English
Sildenafil Citrate
phosphodiesterase 5 inhibitors
treatment outcome
tablets
administration, oral
orphan drug production
hypertension, pulmonary
vasodilator agents
adult
sildenafil
other peripheral vasodilators
evaluation of the transparency committee

---
https://www.amub-ulb.be/system/files/rmb/old/36
2003
false
Belgium
French
Sildenafil Citrate
erectile dysfunction
vasodilator agents
phosphodiesterase 5 inhibitors
journal article

---
http://www.ccne-ethique.fr/sites/default/files/2021-02/avis062.pdf
1999
false
France
French
Sildenafil Citrate
sexuality
sexual partners
france
guidelines
medicalization

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.